GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Gross Margin %

FSNUY (Fresenius SE KGaA) Gross Margin % : 25.40% (As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Fresenius SE KGaA's Gross Profit for the three months ended in Sep. 2024 was $1,513 Mil. Fresenius SE KGaA's Revenue for the three months ended in Sep. 2024 was $5,956 Mil. Therefore, Fresenius SE KGaA's Gross Margin % for the quarter that ended in Sep. 2024 was 25.40%.

Warning Sign:

Fresenius SE & Co KGaA gross margin has been in long-term decline. The average rate of decline per year is -5%.


The historical rank and industry rank for Fresenius SE KGaA's Gross Margin % or its related term are showing as below:

FSNUY' s Gross Margin % Range Over the Past 10 Years
Min: 22.68   Med: 29.28   Max: 32.28
Current: 23.17


During the past 13 years, the highest Gross Margin % of Fresenius SE KGaA was 32.28%. The lowest was 22.68%. And the median was 29.28%.

FSNUY's Gross Margin % is ranked worse than
77.9% of 620 companies
in the Healthcare Providers & Services industry
Industry Median: 40.985 vs FSNUY: 23.17

Fresenius SE KGaA had a gross margin of 25.40% for the quarter that ended in Sep. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Fresenius SE KGaA was -5.00% per year.


Fresenius SE KGaA Gross Margin % Historical Data

The historical data trend for Fresenius SE KGaA's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Gross Margin % Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.22 28.44 27.48 25.09 22.68

Fresenius SE KGaA Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 24.25 20.70 24.65 22.40 25.40

Competitive Comparison of Fresenius SE KGaA's Gross Margin %

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Gross Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Gross Margin % falls into.



Fresenius SE KGaA Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Fresenius SE KGaA's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=5515.8 / 24317.339
=(Revenue - Cost of Goods Sold) / Revenue
=(24317.339 - 18801.527) / 24317.339
=22.68 %

Fresenius SE KGaA's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=1512.8 / 5955.605
=(Revenue - Cost of Goods Sold) / Revenue
=(5955.605 - 4442.841) / 5955.605
=25.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Fresenius SE KGaA  (OTCPK:FSNUY) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Fresenius SE KGaA had a gross margin of 25.40% for the quarter that ended in Sep. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Fresenius SE KGaA Gross Margin % Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.